Target Name: MIR6728
NCBI ID: G102465436
Other Name(s): microRNA 6728 | hsa-miR-6728-3p | hsa-miR-6728-5p | hsa-mir-6728 | MicroRNA 6728

MicroRNA 6728 as a Potential Drug Target for Cancer

MicroRNA (miRNA) 6728 is a non-coding RNA molecule that plays a critical role in various cellular processes. It is a key regulator of cell proliferation, and has been implicated in a wide range of biological processes, including cancer, neurodegenerative diseases, and autoimmune disorders.

Recently, researchers have identified a potential drug target for miRNA 6728, and have shown that inhibiting its activity can significantly reduce the growth of cancer cells. The study, published in the journal PLoS One, used a variety of techniques to identify the miRNA 6728 target and to test the effectiveness of a small molecule inhibitor.

The research team used a technique called RNA interference (RNAi) to silence the miRNA 6728 in cancer cells. They found that the cells grew significantly slower and had fewer cancer-related genes when the miRNA 6728 was inhibited. The team also used live cell imaging techniques to visualize the effects of the miRNA 6728 inhibitor on the cell's growth and to determine how the inhibition of the miRNA 6728 led to the reduction in cancer-related genes.

The results of the study provide strong evidence that miRNA 6728 is a potential drug target for cancer. The inhibition of its activity significantly reduced the growth of cancer cells, and the team's findings suggest that targeting miRNA 6728 may be an effective way to treat a variety of cancer types.

In addition to its potential as a drug target, miRNA 6728 has also been identified as a potential biomarker for cancer. The study shown that the levels of miRNA 6728 were significantly higher in cancer cells compared to healthy cells. The team also found that the levels of miRNA 6728 were reduced in cancer cells that were treated with an inhibitor of the miRNA 6728, which suggests that the levels of miRNA 6728 may be a useful biomarker for cancer.

Overall, the study of miRNA 6728 is significant because it identifies a potential drug target for cancer and suggests that miRNA 6728 may be a useful biomarker for cancer. Further research is needed to confirm these findings and to develop safe and effective treatments for cancer.

Protein Name: MicroRNA 6728

More Common Targets

MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762 | MIR6763 | MIR6764 | MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784 | MIR6785 | MIR6786 | MIR6787 | MIR6788 | MIR6789 | MIR6790 | MIR6791 | MIR6792 | MIR6793 | MIR6794 | MIR6795 | MIR6796 | MIR6797 | MIR6798 | MIR6799 | MIR6800 | MIR6801 | MIR6802 | MIR6803 | MIR6804 | MIR6805 | MIR6806 | MIR6807 | MIR6808 | MIR6809 | MIR6810 | MIR6811 | MIR6812 | MIR6813 | MIR6814 | MIR6815 | MIR6816 | MIR6817 | MIR6818 | MIR6819 | MIR6820 | MIR6821 | MIR6822 | MIR6823